• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the August 11, 2009 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee

Vision impaired people having problems accessing certain pages of a PDF file                           may call (301) 796-3634 for assistance

 

FDA

Disclaimer

 

Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552).

FDA Briefing Material (pdf)

Errata (pdf)

 

***************

 

GE Healthcare

Disclaimer

 

The statements contained in this document(s) are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.

 

DaTSCAN (Ioflupane I 123 Injection) (pdf)